Noble Life Sciences
UEI: KNWJNY921X93
• CAGE: 64VA2
Overview
Awardee Type
Parent
(1 child)
Federal Capability Statement
Noble Life Sciences provides integrated GLP and non-GLP preclinical services designed to accelerate development for drugs, vaccines and medical devices. Services include pharmacology, disease models, early safety assessments, toxicology, biomarker validation and tumor profiling, and analytical testing. We are committed to providing a strong scientific foundation to enable your preclinical decisions.
Keywords
In-vivo preclinical drug testing services, GLP toxicology testing services, in-vivo medical device testing services, in-vivo polyclonal antibody production, In-vivo preclinical vaccine testing services, in-vivo immunogenicity testing services, in-vivo xenograft model development
SBA Special Equipment
Noble has state of the art equipment and trained staff to provide sophisticated imaging techniques. The staff have 10 + years of experience with imaging modalities commonly used in preclinical studies.
Radiography
Computed Tomography (CT) 32 + 64 slice
Magnetic Resonance Imaging (MRI) 1.5T + 3T scanner
Ultrasound
*Flouroscopy
Perkin Elmer IVIS in-vivo imaging
Website
Headquarters
Sykesville, MD
United States
United States
Most Recent Award
Jan. 1, 2024
Calculating
Federal contract and grant recipient
NOBLE LIFE SCIENCES, INC
(UEI KNWJNY921X93, CAGE 64VA2)
is headquartered in Sykesville MD.
Its primary registered NAICS is 541380 Testing Laboratories and Services.
The corporation
was founded in April 2010 and
federally registered in
September 2010.
Federal Award Analysis
Noble Life Sciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NOBLE LIFE SCIENCES, INC
UEI
KNWJNY921X93
CAGE Code
64VA2
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 9, 2010
Initial Registration
Sept. 16, 2010
Last Registration
April 30, 2026
Registration Activation
May 2, 2025
Registration Expiration
April 30, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Subchapter S Corporation
Subchapter S Corporation
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Noble Life Sciences
Contract Vehicles
Noble Life Sciences multi-award contract vehicles
IDV Awards
Noble Life Sciences indefinite delivery vehicle awards
Contract Awards
Noble Life Sciences prime contract awards
Subcontract Awards
Noble Life Sciences subcontract awards
Subgrant Awards
Noble Life Sciences subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Noble Life Sciences